KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Capital Employed (2017 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Return on Capital Employed for 14 consecutive years, with 0.12% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Capital Employed rose 7.0% year-over-year to 0.12%, compared with a TTM value of 0.12% through Jun 2025, up 7.0%, and an annual FY2025 reading of 0.06%, down 1.0% over the prior year.
  • Return on Capital Employed was 0.12% for Q2 2025 at Biomarin Pharmaceutical, up from 0.1% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.12% in Q2 2025 and bottomed at 0.02% in Q4 2021.
  • Average Return on Capital Employed over 4 years is 0.05%, with a median of 0.04% recorded in 2024.
  • The sharpest move saw Return on Capital Employed dropped -1bps in 2021, then rose 7bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.02% in 2021, then soared by 286bps to 0.03% in 2022, then surged by 173bps to 0.08% in 2024, then skyrocketed by 53bps to 0.12% in 2025.
  • Business Quant data shows Return on Capital Employed for BMRN at 0.12% in Q2 2025, 0.1% in Q1 2025, and 0.08% in Q4 2024.